IL10 and inflammatory bowel disease: First, in IL-10-deficient mice, an animal model of IBD, the probiotic bacteria compound VSL#3 enhances the barrier function of intestinal epithelial cells [3], which may be mediated in part by inhibiting the secretion of proinflammatory cytokines such as TNF-α and interferon-γ [48].